More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/TBB [17374-26-4]
Chemical Structure
Chemical Structure
Chemical Structure

TBB [17374-26-4]

Research Use Only
AG-CR1-3660
AdipoGen Life Sciences
CAS Number17374-26-4
DownloadMSDS
Product group Chemicals
Estimated Purity>98%
Molecular Weight434.7
Price on request
Packing Size
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    AdipoGen Life Sciences
  • Product Name
    TBB [17374-26-4]
  • Delivery Days Customer
    10
  • CAS Number
    17374-26-4
  • Certification
    Research Use Only
  • Estimated Purity
    >98%
  • Molecular Formula
    C6HBr4N3
  • Molecular Weight
    434.7
  • Scientific Description
    ATP/GTP-competitive cell permeable casein kinase II (CK2) inhibitor (IC50=0.9microM for rat liver. Less potently inhibits CCK2/cyclin A, GSK3beta and phosphorylase kinase (IC50=15.6, 11.2 and 8.7microM, respectively). Binds to the Val66 residue of CK2 and inhibits the binding of ATP/GTP. Moderate DYRK1A inhibitor (IC50=4.4microM). Induces caspase-dependent apoptosis and degrades hematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. - Chemical. CAS: 17374-26-4. Formula: C6HBr4N3. MW: 434.7. Synthetic. ATP/GTP-competitive cell permeable casein kinase II (CK2) inhibitor (IC50=0.9microM for rat liver. Less potently inhibits CCK2/cyclin A, GSK3beta and phosphorylase kinase (IC50=15.6, 11.2 and 8.7microM, respectively). Binds to the Val66 residue of CK2 and inhibits the binding of ATP/GTP. Moderate DYRK1A inhibitor (IC50=4.4microM). Induces caspase-dependent apoptosis and degrades hematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
  • SMILES
    BrC1=C(Br)C(Br)=C(Br)C2=C1N=NN2
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    51202000

References

  • Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'): S. Sarno, et al.; FEBS Lett. 496, 44 (2001)
  • Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells: M. Ruzzene, et al.; Biochem. J. 364, 41 (2002)
  • Alternative binding modes of an inhibitor to two different kinases: E. De Moliner, et al. Eur. J. Biochem. 270, 3174 (2003)
  • Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole: M.A. Pagano, et al.; J. Med. Chem. 47, 6239 (2004)
  • Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2: P. Zien, et al.; Biochim. Biophys. Acta 1754, 271 (2005)
  • The selectivity of inhibitors of protein kinase CK2: An update: M.A. Pagano, et al.; Biochem. J. 415, 353 (2008)